Shilei Ding - Publications

Affiliations: 
Microbiology and Immunology McGill University, Montreal, QC, Canada 

68/92 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Marchitto L, Chatterjee D, Ding S, Gendron-Lepage G, Tauzin A, Boutin M, Benlarbi M, Medjahed H, Sylla M, Lanctôt H, Durand M, Finzi A, Tremblay C. Humoral Responses Elicited by SARS-CoV-2 mRNA Vaccine in People Living with HIV. Viruses. 15. PMID 37896781 DOI: 10.3390/v15102004  0.318
2023 Leonhardt SA, Purdy MD, Grover JR, Yang Z, Poulos S, McIntire WE, Tatham EA, Erramilli SK, Nosol K, Lai KK, Ding S, Lu M, Uchil PD, Finzi A, Rein A, et al. Antiviral HIV-1 SERINC restriction factors disrupt virus membrane asymmetry. Nature Communications. 14: 4368. PMID 37474505 DOI: 10.1038/s41467-023-39262-2  0.419
2023 Tolbert WD, Chen Y, Sun L, Benlarbi M, Ding S, Manickam R, Pangaro E, Nguyen DN, Gottumukkala S, Côté M, Gonzalez FJ, Finzi A, Tehrani ZR, Sajadi MM, Pazgier M. The molecular basis of the neutralization breadth of the RBD-specific antibody CoV11. Frontiers in Immunology. 14: 1178355. PMID 37334379 DOI: 10.3389/fimmu.2023.1178355  0.66
2023 Guenthoer J, Lilly M, Starr TN, Dadonaite B, Lovendahl KN, Croft JT, Stoddard CI, Chohan V, Ding S, Ruiz F, Kopp MS, Finzi A, Bloom JD, Chu HY, Lee KK, et al. Identification of broad, potent antibodies to functionally constrained regions of SARS-CoV-2 spike following a breakthrough infection. Proceedings of the National Academy of Sciences of the United States of America. 120: e2220948120. PMID 37253011 DOI: 10.1073/pnas.2220948120  0.366
2023 Ding S, Tolbert WD, Zhu H, Lee D, Marchitto L, Higgins T, Zhao X, Nguyen D, Sherburn R, Richard J, Gendron-Lepage G, Medjahed H, Mohammadi M, Abrams C, Pazgier M, et al. Piperidine CD4-Mimetic Compounds Expose Vulnerable Env Epitopes Sensitizing HIV-1-Infected Cells to ADCC. Viruses. 15. PMID 37243271 DOI: 10.3390/v15051185  0.45
2023 Yaffe ZA, Ding S, Sung K, Chohan V, Marchitto L, Doepker L, Ralph D, Nduati R, Matsen FA, Finzi A, Overbaugh J. Reconstruction of a polyclonal ADCC antibody repertoire from an HIV-1 non-transmitting mother. Iscience. 26: 106762. PMID 37216090 DOI: 10.1016/j.isci.2023.106762  0.376
2023 Ding S, Tolbert WD, Zhu H, Lee D, Higgins T, Zhao X, Nguyen D, Sherburn R, Richard J, Lepage GG, Medjahed H, Mohammadi M, Abrams C, Pazgier M, Smith AB, et al. Piperidine CD4-mimetic compounds expose vulnerable Env epitopes sensitizing HIV-1-infected cells to ADCC. Biorxiv : the Preprint Server For Biology. PMID 36993184 DOI: 10.1101/2023.03.23.533923  0.45
2023 Tauzin A, Nicolas A, Ding S, Benlarbi M, Medjahed H, Chatterjee D, Dionne K, Gong SY, Gendron-Lepage G, Bo Y, Perreault J, Goyette G, Gokool L, Arlotto P, Morrisseau C, et al. Spike recognition and neutralization of SARS-CoV-2 Omicron subvariants elicited after the third dose of mRNA vaccine. Cell Reports. 42: 111998. PMID 36656710 DOI: 10.1016/j.celrep.2023.111998  0.644
2023 Bibollet-Ruche F, Russell RM, Ding W, Liu W, Li Y, Wagh K, Wrapp D, Habib R, Skelly AN, Roark RS, Sherrill-Mix S, Wang S, Rando J, Lindemuth E, Cruickshank K, ... ... Ding S, et al. A Germline-Targeting Chimpanzee SIV Envelope Glycoprotein Elicits a New Class of V2-Apex Directed Cross-Neutralizing Antibodies. Mbio. e0337022. PMID 36629414 DOI: 10.1128/mbio.03370-22  0.397
2022 Guenthoer J, Lilly M, Starr TN, Dadonaite B, Lovendahl KN, Croft JT, Stoddard CI, Chohan V, Ding S, Ruiz F, Kopp MS, Finzi A, Bloom JD, Chu HY, Lee KK, et al. Identification of broad, potent antibodies to functionally constrained regions of SARS-CoV-2 spike following a breakthrough infection. Biorxiv : the Preprint Server For Biology. PMID 36561191 DOI: 10.1101/2022.12.15.520606  0.368
2022 Chen Y, Prévost J, Ullah I, Romero H, Lisi V, Tolbert WD, Grover JR, Ding S, Gong SY, Beaudoin-Bussières G, Gasser R, Benlarbi M, Vézina D, Anand SP, Chatterjee D, et al. Molecular basis for antiviral activity of two pediatric neutralizing antibodies targeting SARS-CoV-2 Spike RBD. Iscience. 105783. PMID 36514310 DOI: 10.1016/j.isci.2022.105783  0.674
2022 Matsumoto K, Kuwata T, Tolbert WD, Richard J, Ding S, Prévost J, Takahama S, Judicate GP, Ueno T, Nakata H, Kobayakawa T, Tsuji K, Tamamura H, Smith AB, Pazgier M, et al. Characterization of a Novel CD4 Mimetic Compound YIR-821 against HIV-1 Clinical Isolates. Journal of Virology. e0163822. PMID 36511698 DOI: 10.1128/jvi.01638-22  0.387
2022 Gong SY, Ding S, Benlarbi M, Chen Y, Vézina D, Marchitto L, Beaudoin-Bussières G, Goyette G, Bourassa C, Bo Y, Medjahed H, Levade I, Pazgier M, Côté M, Richard J, et al. Temperature Influences the Interaction between SARS-CoV-2 Spike from Omicron Subvariants and Human ACE2. Viruses. 14. PMID 36298733 DOI: 10.3390/v14102178  0.658
2022 Tauzin A, Gong SY, Chatterjee D, Ding S, Painter MM, Goel RR, Beaudoin-Bussières G, Marchitto L, Boutin M, Laumaea A, Okeny J, Gendron-Lepage G, Bourassa C, Medjahed H, Goyette G, et al. A boost with SARS-CoV-2 BNT162b2 mRNA vaccine elicits strong humoral responses independently of the interval between the first two doses. Cell Reports. 41: 111554. PMID 36244343 DOI: 10.1016/j.celrep.2022.111554  0.636
2022 Ratnapriya S, Braun AR, Cervera Benet H, Carlson D, Ding S, Paulson CN, Mishra N, Sachs JN, Aldrich CC, Finzi A, Herschhorn A. Broad Tricyclic Ring Inhibitors Block SARS-CoV-2 Spike Function Required for Viral Entry. Acs Infectious Diseases. PMID 36153947 DOI: 10.1021/acsinfecdis.1c00658  0.312
2022 Ding S, Ullah I, Gong SY, Grover J, Mohammadi M, Chen Y, Vézina D, Beaudoin-Bussières G, Verma VT, Goyette G, Gaudette F, Richard J, Yang D, Smith AB, Pazgier M, et al. VE607 Stabilizes SARS-CoV-2 Spike In the "RBD-up" Conformation and Inhibits Viral Entry. Iscience. 104528. PMID 35677392 DOI: 10.1016/j.isci.2022.104528  0.668
2022 Boutin M, Vézina D, Ding S, Prévost J, Laumaea A, Marchitto L, Anand SP, Medjahed H, Gendron-Lepage G, Bourassa C, Goyette G, Clark A, Richard J, Finzi A. Temsavir Treatment of HIV-1-Infected Cells Decreases Envelope Glycoprotein Recognition by Broadly Neutralizing Antibodies. Mbio. e0057722. PMID 35475646 DOI: 10.1128/mbio.00577-22  0.473
2022 Ding S, Gong SY, Grover J, Mohammadi M, Chen Y, Vézina D, Beaudoin-Bussières G, Verma VT, Goyette G, Richard J, Yang D, Smith AB, Pazgier M, Côté M, Abrams C, et al. VE607 Stabilizes SARS-CoV-2 Spike In the "RBD-up" Conformation and Inhibits Viral Entry. Biorxiv : the Preprint Server For Biology. PMID 35233570 DOI: 10.1101/2022.02.03.479007  0.672
2022 Chatterjee D, Tauzin A, Marchitto L, Gong SY, Boutin M, Bourassa C, Beaudoin-Bussières G, Bo Y, Ding S, Laumaea A, Vézina D, Perreault J, Gokool L, Morrisseau C, Arlotto P, et al. SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-week interval between doses. Cell Reports. 38: 110429. PMID 35216664 DOI: 10.1016/j.celrep.2022.110429  0.652
2022 Yang Z, Han Y, Ding S, Shi W, Zhou T, Finzi A, Kwong PD, Mothes W, Lu M. SARS-CoV-2 Variants Increase Kinetic Stability of Open Spike Conformations as an Evolutionary Strategy. Mbio. e0322721. PMID 35164561 DOI: 10.1128/mbio.03227-21  0.306
2022 Beaudoin-Bussières G, Chen Y, Ullah I, Prévost J, Tolbert WD, Symmes K, Ding S, Benlarbi M, Gong SY, Tauzin A, Gasser R, Chatterjee D, Vézina D, Goyette G, Richard J, et al. A Fc-enhanced NTD-binding non-neutralizing antibody delays virus spread and synergizes with a nAb to protect mice from lethal SARS-CoV-2 infection. Cell Reports. 38: 110368. PMID 35123652 DOI: 10.1016/j.celrep.2022.110368  0.336
2021 Ding S, Adam D, Beaudoin-Bussières G, Tauzin A, Gong SY, Gasser R, Laumaea A, Anand SP, Privé A, Bourassa C, Medjahed H, Prévost J, Charest H, Richard J, Brochiero E, et al. SARS-CoV-2 Spike Expression at the Surface of Infected Primary Human Airway Epithelial Cells. Viruses. 14. PMID 35062211 DOI: 10.3390/v14010005  0.33
2021 Li W, Chen Y, Prévost J, Ullah I, Lu M, Gong SY, Tauzin A, Gasser R, Vézina D, Anand SP, Goyette G, Chaterjee D, Ding S, Tolbert WD, Grunst MW, et al. Structural basis and mode of action for two broadly neutralizing antibodies against SARS-CoV-2 emerging variants of concern. Cell Reports. 110210. PMID 34971573 DOI: 10.1016/j.celrep.2021.110210  0.674
2021 Zhang P, Narayanan E, Liu Q, Tsybovsky Y, Boswell K, Ding S, Hu Z, Follmann D, Lin Y, Miao H, Schmeisser H, Rogers D, Falcone S, Elbashir SM, Presnyak V, et al. A multiclade env-gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques. Nature Medicine. 27: 2234-2245. PMID 34887575 DOI: 10.1038/s41591-021-01574-5  0.451
2021 Chen Y, Sun L, Ullah I, Beaudoin-Bussières G, Anand SP, Hederman AP, Tolbert WD, Sherburn R, Nguyen DN, Marchitto L, Ding S, Wu D, Luo Y, Gottumukkala S, Moran S, et al. Engineered ACE2-Fc counters murine lethal SARS-CoV-2 infection through direct neutralization and Fc-effector activities. Biorxiv : the Preprint Server For Biology. PMID 34845451 DOI: 10.1101/2021.11.24.469776  0.311
2021 Richard J, Nguyen DN, Tolbert WD, Gasser R, Ding S, Vézina D, Yu Gong S, Prévost J, Gendron-Lepage G, Medjahed H, Gottumukkala S, Finzi A, Pazgier M. Across Functional Boundaries: Making Nonneutralizing Antibodies To Neutralize HIV-1 and Mediate Fc-Mediated Effector Killing of Infected Cells. Mbio. e0140521. PMID 34579568 DOI: 10.1128/mBio.01405-21  0.453
2021 Li W, Chen Y, Prévost J, Ullah I, Lu M, Gong SY, Tauzin A, Gasser R, Vézina D, Anand SP, Goyette G, Chaterjee D, Ding S, Tolbert WD, Grunst MW, et al. Structural Basis and Mode of Action for Two Broadly Neutralizing Antibodies Against SARS-CoV-2 Emerging Variants of Concern. Biorxiv : the Preprint Server For Biology. PMID 34373853 DOI: 10.1101/2021.08.02.454546  0.673
2021 Anand SP, Ding S, Tolbert WD, Prévost J, Richard J, Gil HM, Gendron-Lepage G, Cheung WF, Wang H, Pastora R, Saxena H, Wakarchuk W, Medjahed H, Wines BD, Hogarth PM, et al. Enhanced ability of plant-derived PGT121 glycovariants to eliminate HIV-1-infected cells. Journal of Virology. JVI0079621. PMID 34232070 DOI: 10.1128/JVI.00796-21  0.432
2020 Vézina D, Gong SY, Tolbert WD, Ding S, Nguyen D, Richard J, Gendron-Lepage G, Melillo B, Smith AB, Pazgier M, Finzi A. Stabilizing the HIV-1 envelope glycoprotein State 2A conformation. Journal of Virology. PMID 33298541 DOI: 10.1128/JVI.01620-20  0.315
2020 Prévost J, Gasser R, Beaudoin-Bussières G, Richard J, Duerr R, Laumaea A, Anand SP, Goyette G, Benlarbi M, Ding S, Medjahed H, Lewin A, Perreault J, Tremblay T, Gendron-Lepage G, et al. Cross-sectional evaluation of humoral responses against SARS-CoV-2 Spike. Cell Reports. Medicine. 100126. PMID 33015650 DOI: 10.1016/j.xcrm.2020.100126  0.698
2020 Tolbert WD, Sherburn R, Gohain N, Ding S, Flinko R, Orlandi C, Ray K, Finzi A, Lewis GK, Pazgier M. Defining rules governing recognition and Fc-mediated effector functions to the HIV-1 co-receptor binding site. Bmc Biology. 18: 91. PMID 32693837 DOI: 10.1186/S12915-020-00819-Y  0.537
2020 Prévost J, Gasser R, Beaudoin-Bussières G, Richard J, Duerr R, Laumaea A, Anand SP, Goyette G, Ding S, Medjahed H, Lewin A, Perreault J, Tremblay T, Gendron-Lepage G, Gauthier N, et al. Cross-sectional evaluation of humoral responses against SARS-CoV-2 Spike. Biorxiv : the Preprint Server For Biology. PMID 32577637 DOI: 10.1101/2020.06.08.140244  0.696
2020 Grenier MC, Ding S, Vézina D, Chapleau JP, Tolbert WD, Sherburn R, Schön A, Somisetti S, Abrams CF, Pazgier M, Finzi A, Smith AB. Optimization of Small Molecules That Sensitize HIV-1 Infected Cells to Antibody-Dependent Cellular Cytotoxicity. Acs Medicinal Chemistry Letters. 11: 371-378. PMID 32184972 DOI: 10.1021/Acsmedchemlett.9B00445  0.531
2019 Ding S, Grenier MC, Tolbert WD, Vézina D, Sherburn R, Richard J, Prévost J, Chapleau JP, Gendron-Lepage G, Medjahed H, Abrams C, Sodroski J, Pazgier M, Smith AB, Finzi A. A new family of small-molecule CD4-mimetic compounds contact the highly conserved aspartic acid 368 of HIV-1 gp120 and mediates ADCC. Journal of Virology. PMID 31554684 DOI: 10.1128/Jvi.01325-19  0.48
2019 Ding S, Gasser R, Gendron-Lepage G, Medjahed H, Tolbert WD, Sodroski J, Pazgier M, Finzi A. CD4 Incorporation into HIV-1 Viral Particles Exposes Envelope Epitopes Recognized by CD4-induced Antibodies. Journal of Virology. PMID 31484748 DOI: 10.1128/Jvi.01403-19  0.451
2019 Tuen M, Bimela JS, Banin AN, Ding S, Harkins GW, Weiss S, Itri V, Durham AR, Porcella SF, Soni S, Mayr L, Meli J, Torimiro JN, Tongo M, Wang X, et al. Immune Correlates of Disease Progression in Linked HIV-1 Infection. Frontiers in Immunology. 10: 1062. PMID 31139189 DOI: 10.3389/Fimmu.2019.01062  0.53
2019 Alsahafi N, Bakouche N, Kazemi M, Richard J, Ding S, Bhattacharyya S, Das D, Anand SP, Prévost J, Tolbert WD, Lu H, Medjahed H, Gendron-Lepage G, Ortega Delgado GG, Kirk S, et al. An Asymmetric Opening of HIV-1 Envelope Mediates Antibody-Dependent Cellular Cytotoxicity. Cell Host & Microbe. 25: 578-587.e5. PMID 30974085 DOI: 10.1016/J.Chom.2019.03.002  0.5
2019 Anand SP, Grover JR, Tolbert WD, Prévost J, Richard J, Ding S, Baril S, Medjahed H, Evans DT, Pazgier M, Mothes W, Finzi A. Antibody-induced internalization of HIV-1 Env proteins limits the surface expression of the closed conformation of Env. Journal of Virology. PMID 30894474 DOI: 10.1128/Jvi.00293-19  0.537
2019 Williams KL, Stumpf M, Naiman NE, Ding S, Garrett M, Gobillot T, Vézina D, Dusenbury K, Ramadoss NS, Basom R, Kim PS, Finzi A, Overbaugh J. Identification of HIV gp41-specific antibodies that mediate killing of infected cells. Plos Pathogens. 15: e1007572. PMID 30779811 DOI: 10.1371/Journal.Ppat.1007572  0.533
2019 Bibollet-Ruche F, Russell RM, Liu W, Stewart-Jones GBE, Sherrill-Mix S, Li Y, Learn GH, Smith AG, Gondim MVP, Plenderleith LJ, Decker JM, Easlick JL, Wetzel KS, Collman RG, Ding S, et al. CD4 receptor diversity in chimpanzees protects against SIV infection. Proceedings of the National Academy of Sciences of the United States of America. PMID 30718403 DOI: 10.1073/Pnas.1821197116  0.34
2018 Madani N, Princiotto AM, Mach L, Ding S, Prevost J, Richard J, Hora B, Sutherland L, Zhao CA, Conn BP, Bradley T, Moody MA, Melillo B, Finzi A, Haynes BF, et al. A CD4-mimetic compound enhances vaccine efficacy against stringent immunodeficiency virus challenge. Nature Communications. 9: 2363. PMID 29915222 DOI: 10.1038/S41467-018-04758-9  0.545
2018 Richard J, Prévost J, Baxter AE, von Bredow B, Ding S, Medjahed H, Delgado GG, Brassard N, Stürzel CM, Kirchhoff F, Hahn BH, Parsons MS, Kaufmann DE, Evans DT, Finzi A. Uninfected Bystander Cells Impact the Measurement of HIV-Specific Antibody-Dependent Cellular Cytotoxicity Responses. Mbio. 9. PMID 29559570 DOI: 10.1128/Mbio.00358-18  0.553
2017 Prévost J, Richard J, Ding S, Pacheco B, Charlebois R, Hahn BH, Kaufmann DE, Finzi A. Envelope glycoproteins sampling states 2/3 are susceptible to ADCC by sera from HIV-1-infected individuals. Virology. 515: 38-45. PMID 29248757 DOI: 10.1016/J.Virol.2017.12.002  0.518
2017 Richard J, Prévost J, Alsahafi N, Ding S, Finzi A. Impact of HIV-1 Envelope Conformation on ADCC Responses. Trends in Microbiology. PMID 29162391 DOI: 10.1016/J.Tim.2017.10.007  0.51
2017 Tolbert WD, Gohain N, Alsahafi N, Van V, Orlandi C, Ding S, Martin L, Finzi A, Lewis GK, Ray K, Pazgier M. Targeting the Late Stage of HIV-1 Entry for Antibody-Dependent Cellular Cytotoxicity: Structural Basis for Env Epitopes in the C11 Region. Structure (London, England : 1993). PMID 29056481 DOI: 10.1016/J.Str.2017.09.009  0.499
2017 Richard J, Ding S, Finzi A. Unlocking HIV-1 Env: implications for antibody attack. Aids Research and Therapy. 14: 42. PMID 28893275 DOI: 10.1186/S12981-017-0168-5  0.532
2017 Richard J, Prévost J, von Bredow B, Ding S, Brassard N, Medjahed H, Coutu M, Melillo B, Bibollet-Ruche F, Hahn BH, Kaufmann DE, Smith AB, Sodroski J, Sauter D, Kirchhoff F, et al. BST-2 Expression Modulates Small CD4 Mimetic Sensitization of HIV-1-infected cells to ADCC. Journal of Virology. PMID 28331088 DOI: 10.1128/Jvi.00219-17  0.532
2017 Wang Y, Pan Q, Ding S, Wang Z, Yu J, Finzi A, Liu SL, Liang C. The V3-loop of HIV-1 Env determines viral susceptibility to IFITM3 impairment of viral infectivity. Journal of Virology. PMID 28100616 DOI: 10.1128/Jvi.02441-16  0.759
2016 Pacheco B, Alsahafi N, Debbeche O, Prévost J, Ding S, Chapleau JP, Herschhorn A, Madani N, Princiotto A, Melillo B, Gu C, Zeng X, Mao Y, Smith AB, Sodroski J, et al. Residues in the gp41 Ectodomain Regulate HIV-1 Envelope Glycoprotein Conformational Transitions Induced by gp120-directed Inhibitors. Journal of Virology. PMID 28003492 DOI: 10.1128/Jvi.02219-16  0.435
2016 Beitari S, Ding S, Pan Q, Finzi A, Liang C. The effect of HIV-1 Env on SERINC5 antagonism. Journal of Virology. PMID 27928004 DOI: 10.1128/Jvi.02214-16  0.518
2016 Choi E, Michalski CJ, Choo SH, Kim GN, Banasikowska E, Lee S, Wu K, An HY, Mills A, Schneider S, Bredeek UF, Coulston DR, Ding S, Finzi A, Tian M, et al. First Phase I human clinical trial of a killed whole-HIV-1 vaccine: demonstration of its safety and enhancement of anti-HIV antibody responses. Retrovirology. 13: 82. PMID 27894306 DOI: 10.1186/S12977-016-0317-2  0.487
2016 Ding S, Verly MM, Princiotto A, Melillo B, Moody T, Bradley T, Easterhoff D, Roger M, Hahn BH, Madani N, Smith Iii AB, Haynes BF, Sodroski JG, Finzi A. Small Molecule CD4-Mimetics Sensitize HIV-1-infected Cells to ADCC by Antibodies Elicited by Multiple Envelope Glycoprotein Immunogens in Non-Human Primates. Aids Research and Human Retroviruses. PMID 27846736 DOI: 10.1089/Aid.2016.0246  0.583
2016 Gohain N, Tolbert WD, Orlandi C, Richard J, Ding S, Chen X, Bonsor DA, Sundberg EJ, Lu W, Ray K, Finzi A, Lewis GK, Pazgier M. Molecular basis for epitope recognition by non-neutralizing anti-gp41 antibody F240. Scientific Reports. 6: 36685. PMID 27827447 DOI: 10.1038/Srep36685  0.491
2016 Richard J, Pacheco B, Gohain N, Veillette M, Ding S, Alsahafi N, Tolbert WD, Prévost J, Chapleau JP, Coutu M, Jia M, Brassard N, Park J, Courter JR, Melillo B, et al. Co-receptor Binding Site Antibodies Enable CD4-Mimetics to Expose Conserved Anti-cluster A ADCC Epitopes on HIV-1 Envelope Glycoproteins. Ebiomedicine. PMID 27633463 DOI: 10.1016/J.Ebiom.2016.09.004  0.545
2016 Ding S, Medjahed H, Prévost J, Coutu M, Xiang SH, Finzi A. Lineage-specific differences in the gp120 Inner Domain Layer 3 of Human and Simian Immunodeficiency Viruses. Journal of Virology. PMID 27535053 DOI: 10.1128/Jvi.01215-16  0.416
2016 Ding S, Tolbert WD, Prévost J, Pacheco B, Coutu M, Debbeche O, Xiang SH, Pazgier M, Finzi A. A Highly Conserved gp120 Inner Domain Residue Modulates Env Conformation and Trimer Stability. Journal of Virology. PMID 27384653 DOI: 10.1128/Jvi.01068-16  0.398
2016 Richard J, Veillette M, Ding S, Zoubchenok D, Alsahafi N, Coutu M, Brassard N, Park J, Courter JR, Melillo B, Smith AB, Shaw GM, Hahn BH, Sodroski J, Kaufmann DE, et al. Small CD4 Mimetics Prevent HIV-1 Uninfected Bystander CD4 + T Cell Killing Mediated by Antibody-dependent Cell-mediated Cytotoxicity. Ebiomedicine. 3: 122-34. PMID 26870823 DOI: 10.1016/J.Ebiom.2015.12.004  0.483
2015 Alsahafi N, Ding S, Richard J, Markle T, Brassard N, Walker B, Lewis GK, Kaufmann DE, Brockman MA, Finzi A. Nef proteins from HIV-1 elite controllers are inefficient at preventing ADCC. Journal of Virology. PMID 26719277 DOI: 10.1128/Jvi.02973-15  0.543
2015 Ding S, Veillette M, Coutu M, Prévost J, Scharf L, Bjorkman PJ, Ferrari G, Robinson JE, Stürzel C, Hahn BH, Sauter D, Kirchhoff F, Lewis GK, Pazgier M, Finzi A. A Highly-Conserved Residue of the HIV-1-gp120 Inner Domain is Important for ADCC Responses Mediated by Anti-Cluster A Antibodies. Journal of Virology. PMID 26637462 DOI: 10.1128/Jvi.02779-15  0.518
2015 Yu J, Li M, Wilkins J, Ding S, Swartz TH, Esposito AM, Zheng YM, Freed EO, Liang C, Chen BK, Liu SL. IFITM Proteins Restrict HIV-1 Infection by Antagonizing the Envelope Glycoprotein. Cell Reports. PMID 26387945 DOI: 10.1016/J.Celrep.2015.08.055  0.713
2015 Jia R, Ding S, Pan Q, Liu SL, Qiao W, Liang C. The C-terminal sequence of IFITM1 regulates its anti-HIV-1 activity. Plos One. 10: e0118794. PMID 25738301 DOI: 10.1371/Journal.Pone.0118794  0.64
2015 Qian J, Le Duff Y, Wang Y, Pan Q, Ding S, Zheng YM, Liu SL, Liang C. Primate lentiviruses are differentially inhibited by interferon-induced transmembrane proteins. Virology. 474: 10-8. PMID 25463599 DOI: 10.1016/J.Virol.2014.10.015  0.576
2014 Ding S, Pan Q, Liu SL, Liang C. HIV-1 mutates to evade IFITM1 restriction. Virology. 454: 11-24. PMID 24725927 DOI: 10.1016/J.Virol.2014.01.020  0.647
2013 Liu Z, Pan Q, Ding S, Qian J, Xu F, Zhou J, Cen S, Guo F, Liang C. The interferon-inducible MxB protein inhibits HIV-1 infection. Cell Host & Microbe. 14: 398-410. PMID 24055605 DOI: 10.1016/J.Chom.2013.08.015  0.519
2013 Li K, Markosyan RM, Zheng YM, Golfetto O, Bungart B, Li M, Ding S, He Y, Liang C, Lee JC, Gratton E, Cohen FS, Liu SL. IFITM proteins restrict viral membrane hemifusion. Plos Pathogens. 9: e1003124. PMID 23358889 DOI: 10.1371/Journal.Ppat.1003124  0.641
2013 Liu Z, Pan Q, Ding S, Qian J, Xu F, Zhou J, Cen S, Guo F, Liang C. The interferon-induced MxB protein inhibits an early step of HIV-1 infection Retrovirology. 10. DOI: 10.1186/1742-4690-10-S1-P48  0.404
2012 Jia R, Pan Q, Ding S, Rong L, Liu SL, Geng Y, Qiao W, Liang C. The N-terminal region of IFITM3 modulates its antiviral activity by regulating IFITM3 cellular localization. Journal of Virology. 86: 13697-707. PMID 23055554 DOI: 10.1128/Jvi.01828-12  0.599
2012 Ndongwe TP, Adedeji AO, Michailidis E, Ong YT, Hachiya A, Marchand B, Ryan EM, Rai DK, Kirby KA, Whatley AS, Burke DH, Johnson M, Ding S, Zheng YM, Liu SL, et al. Biochemical, inhibition and inhibitor resistance studies of xenotropic murine leukemia virus-related virus reverse transcriptase. Nucleic Acids Research. 40: 345-59. PMID 21908397 DOI: 10.1093/Nar/Gkr694  0.635
Low-probability matches (unlikely to be authored by this person)
2021 Ullah I, Prévost J, Ladinsky MS, Stone H, Lu M, Anand SP, Beaudoin-Bussières G, Benlarbi M, Ding S, Gasser R, Fink C, Chen Y, Tauzin A, Goyette G, Bourassa C, et al. Live imaging of SARS-CoV-2 infection in mice reveals neutralizing antibodies require Fc function for optimal efficacy. Biorxiv : the Preprint Server For Biology. PMID 33791699 DOI: 10.1101/2021.03.22.436337  0.296
2023 Laumaea A, Marchitto L, Ding S, Beaudoin-Bussières G, Prévost J, Gasser R, Chatterjee D, Gendron-Lepage G, Medjahed H, Chen HC, Smith AB, Ding H, Kappes JC, Hahn BH, Kirchhoff F, et al. Small CD4 mimetics sensitize HIV-1-infected macrophages to antibody-dependent cellular cytotoxicity. Cell Reports. 42: 111983. PMID 36640355 DOI: 10.1016/j.celrep.2022.111983  0.292
2020 Ding S, Laumaea A, Gasser R, Medjahed H, Pancera M, Stamatatos L, McGuire A, Bazin R, Finzi A. Antibody binding to SARS-CoV-2 S glycoprotein correlates with, but does not predict neutralization. Biorxiv : the Preprint Server For Biology. PMID 32935094 DOI: 10.1101/2020.09.08.287482  0.291
2022 Chen Y, Sun L, Ullah I, Beaudoin-Bussières G, Anand SP, Hederman AP, Tolbert WD, Sherburn R, Nguyen DN, Marchitto L, Ding S, Wu D, Luo Y, Gottumukkala S, Moran S, et al. Engineered ACE2-Fc counters murine lethal SARS-CoV-2 infection through direct neutralization and Fc-effector activities. Science Advances. 8: eabn4188. PMID 35857504 DOI: 10.1126/sciadv.abn4188  0.29
2020 Ding S, Laumaea A, Benlarbi M, Beaudoin-Bussières G, Gasser R, Medjahed H, Pancera M, Stamatatos L, McGuire AT, Bazin R, Finzi A. Antibody Binding to SARS-CoV-2 S Glycoprotein Correlates with but Does Not Predict Neutralization. Viruses. 12. PMID 33114742 DOI: 10.3390/v12111214  0.286
2021 Ullah I, Prévost J, Ladinsky MS, Stone H, Lu M, Anand SP, Beaudoin-Bussières G, Symmes K, Benlarbi M, Ding S, Gasser R, Fink C, Chen Y, Tauzin A, Goyette G, et al. Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy. Immunity. PMID 34453881 DOI: 10.1016/j.immuni.2021.08.015  0.275
2020 Lu M, Uchil PD, Li W, Zheng D, Terry DS, Gorman J, Shi W, Zhang B, Zhou T, Ding S, Gasser R, Prévost J, Beaudoin-Bussières G, Anand SP, Laumaea A, et al. Real-Time Conformational Dynamics of SARS-CoV-2 Spikes on Virus Particles. Cell Host & Microbe. PMID 33242391 DOI: 10.1016/j.chom.2020.11.001  0.273
2021 Prévost J, Richard J, Gasser R, Ding S, Fage C, Anand SP, Adam D, Vergara NG, Tauzin A, Benlarbi M, Gong SY, Goyette G, Privé A, Moreira S, Charest H, et al. Impact of temperature on the affinity of SARS-CoV-2 Spike glycoprotein for host ACE2. The Journal of Biological Chemistry. 101151. PMID 34478710 DOI: 10.1016/j.jbc.2021.101151  0.269
2020 Lu M, Uchil PD, Li W, Zheng D, Terry DS, Gorman J, Shi W, Zhang B, Zhou T, Ding S, Gasser R, Prevost J, Beaudoin-Bussieres G, Anand SP, Laumaea A, et al. Real-time conformational dynamics of SARS-CoV-2 spikes on virus particles. Biorxiv : the Preprint Server For Biology. PMID 32935100 DOI: 10.1101/2020.09.10.286948  0.252
2021 Prévost J, Richard J, Gasser R, Ding S, Fage C, Anand SP, Adam D, Vergara NG, Tauzin A, Benlarbi M, Gong SY, Goyette G, Privé A, Moreira S, Charest H, et al. Impact of temperature on the affinity of SARS-CoV-2 Spike for ACE2. Biorxiv : the Preprint Server For Biology. PMID 34268505 DOI: 10.1101/2021.07.09.451812  0.247
2023 Wang Z, Pan Q, Ma L, Zhao J, McIntosh F, Liu Z, Ding S, Lin R, Chen S, Finzi A, Liang C. Anthracyclines inhibit SARS-CoV-2 infection. Virus Research. 199164. PMID 37379907 DOI: 10.1016/j.virusres.2023.199164  0.225
2021 Gasser R, Cloutier M, Prévost J, Fink C, Ducas É, Ding S, Dussault N, Landry P, Tremblay T, Laforce-Lavoie A, Lewin A, Beaudoin-Bussières G, Laumaea A, Medjahed H, Larochelle C, et al. Major role of IgM in the neutralizing activity of convalescent plasma against SARS-CoV-2. Cell Reports. 108790. PMID 33596407 DOI: 10.1016/j.celrep.2021.108790  0.209
2023 Sannier G, Nicolas A, Dubé M, Marchitto L, Nayrac M, Tastet O, Chatterjee D, Tauzin A, Lima-Barbosa R, Laporte M, Cloutier R, Sreng Flores AM, Boutin M, Gong SY, Benlarbi M, ... Ding S, et al. A third SARS-CoV-2 mRNA vaccine dose in people receiving hemodialysis overcomes B cell defects but elicits a skewed CD4 T cell profile. Cell Reports. Medicine. 100955. PMID 36863335 DOI: 10.1016/j.xcrm.2023.100955  0.189
2022 Laumaea AE, Lewin A, Chatterjee D, Marchitto L, Ding S, Gendron-Lepage G, Goyette G, Allard MÈ, Simard C, Tremblay T, Perreault J, Duerr R, Finzi A, Bazin R. COVID-19 vaccine humoral response in frequent platelet donors with plateletpheresis-associated lymphopenia. Transfusion. PMID 35919021 DOI: 10.1111/trf.17037  0.128
2016 Fu J, Hua M, Ding S, Chen X, Wu R, Liu S, Han J, Wang C, Du H, Yang Y, Yang J. Stability and its mechanism in Ag/CoOx/Ag interface-type resistive switching device. Scientific Reports. 6: 35630. PMID 27759116 DOI: 10.1038/srep35630  0.055
2018 Wang Z, Ding S, Li Z, Li F, Zhao T, Li J, Lin H, Chen C. Synthesis of a magnetic polystyrene-based cation-exchange resin and its utilization for the efficient removal of cadmium (II). Water Science and Technology : a Journal of the International Association On Water Pollution Research. 2017: 770-781. PMID 30016295 DOI: 10.2166/wst.2018.239  0.051
2019 Ding S, Xue M, Liang Z, Liu Z, Li R, Cao S, Sun Y, Zhao J, Yang W, Yang J. Spin switching temperature modulated by the magnetic field and spontaneous exchange bias effect in single crystal SmFeO3. Journal of Physics. Condensed Matter : An Institute of Physics Journal. PMID 31272085 DOI: 10.1088/1361-648X/ab2f51  0.034
2010 Ding SL, Zhang GS. [FTIR spectroscopic study on natural aragonitic ceramics-bivalve shells of Hyriopsis cumingii]. Guang Pu Xue Yu Guang Pu Fen Xi = Guang Pu. 26: 2200-2. PMID 17361709  0.032
2020 Peng Y, Ding S, Cheng M, Hu Q, Yang J, Wang F, Xue M, Liu Z, Lin Z, Avdeev M, Hou Y, Yang W, Zheng Y, Yang J. Magnetic Structure and Metamagnetic Transitions in the van der Waals Antiferromagnet CrPS. Advanced Materials (Deerfield Beach, Fla.). e2001200. PMID 32500563 DOI: 10.1002/Adma.202001200  0.031
2020 Ding S, Peng Y, Xue M, Liu Z, Liang Z, Yang W, Sun Y, Zhao J, Wang C, Liu S, Han J, Yang J. Magnetic phase diagram of CrPS4 and its exchange interaction in contact with NiFe. Journal of Physics. Condensed Matter : An Institute of Physics Journal. PMID 32554867 DOI: 10.1088/1361-648X/ab9e2d  0.029
2010 Ding S, Liu N, Li X, Peng L, Guo X, Ding W. Silica nanotubes and their assembly assisted by boric acid to hierachical mesostructures. Langmuir : the Acs Journal of Surfaces and Colloids. 26: 4572-5. PMID 20199082 DOI: 10.1021/La904851R  0.025
2021 Kim C, Liang D, Han Y, Ding S, Li K, Yun C, Yang W, Han J, Liu S, Du H, Wang C, Yang J. Micromagnetic simulation of microstructure effect for binary-main-phase Nd-Ce-Fe-B magnets. Journal of Physics. Condensed Matter : An Institute of Physics Journal. PMID 34348249 DOI: 10.1088/1361-648X/ac1aa1  0.023
2022 Ding S, Liang Z, Go D, Yun C, Xue M, Liu Z, Becker S, Yang W, Du H, Wang C, Yang Y, Jakob G, Kläui M, Mokrousov Y, Yang J. Observation of the Orbital Rashba-Edelstein Magnetoresistance. Physical Review Letters. 128: 067201. PMID 35213174 DOI: 10.1103/PhysRevLett.128.067201  0.02
2020 Ding S, Ross A, Go D, Baldrati L, Ren Z, Freimuth F, Becker S, Kammerbauer F, Yang J, Jakob G, Mokrousov Y, Kläui M. Harnessing Orbital-to-Spin Conversion of Interfacial Orbital Currents for Efficient Spin-Orbit Torques. Physical Review Letters. 125: 177201. PMID 33156648 DOI: 10.1103/PhysRevLett.125.177201  0.01
Hide low-probability matches.